NICE Clears Hepatitis C Drug

News   Sep 29, 2016

 
NICE Clears Hepatitis C Drug
 
 
 

RELATED ARTICLES

First Step Toward CRISPR Cure for Lou Gehrig’s Disease

News

For the first time researchers have used CRISPR-Cas9 gene editing to disable a defective gene that causes amyotrophic lateral sclerosis, or Lou Gehrig’s disease, in mice, extending their lifespan by 25 percent.

READ MORE

Innovative ALS Therapy Startup Wins Golden Ticket Funding From Amgen

News

Amgen and LabCentral have announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral.

READ MORE

Children With Congenital Zika Virus Infection Face Serious Challenges as They Age

News

The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE